# Stomach Cancer Exosome-based Detection

> **NCT06342427** · — · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 809 (actual)

## Conditions studied

- Gastric Cancer
- Gastric Adenocarcinoma
- Gastric Cancer Stage
- Gastric Neoplasm
- Gastric Lesion
- Gastric Cancer in Situ
- Gastric Cancer Stage IV
- Gastric Cancer Stage IIIB
- Gastric Cancer Stage III
- Gastric Cancer Stage IB
- Gastric Cancer Stage IA
- Gastric Cancer, Stage 0
- Gastric Cancer Stage IIIA
- Gastric Cancer Stage II
- Gastric Cancer TNM Staging
- Gastric Cancer Metastatic to Lung
- Gastric Cancer Metastatic to Liver
- Gastric Cancer Stage I
- Gastric Cancer TNM Staging Primary Tumor (T) T2B

## Interventions

- **DIAGNOSTIC_TEST:** DESTINEX

## Key facts

- **NCT ID:** NCT06342427
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-15
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-06-15
- **Target enrollment:** 809 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06342427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06342427, "Stomach Cancer Exosome-based Detection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06342427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*